Delivery Order SPE2DR25D6028-SPE2DR26FATQA
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Hepatitis B vaccine (1 mL, 10-unit package) with a ceiling value of $13,899.53. This firm fixed-price delivery order, with an ultimate completion date of July 2, 2025, represents a non-competitive award issued under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,803.04 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Hepatitis B vaccine (1 mL, 10-unit packages). This firm fixed price delivery order, with an ultimate completion date of October 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,964.04 to AmerisourceBergen Drug Corp for Hepatitis B vaccine (1ML, 10-count units) on August 15, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,259.56 to AmerisourceBergen Drug Corp for Hepatitis B vaccine (1ml, 10-unit packages) on November 7, 2025, with completion expected by December 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to support federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,171.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 8, 2025, for the supply of Hyperhep B Vial 5ML, a hepatitis B vaccine product. The order, which is a non-set-aside competitive award, is scheduled for completion by December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $9,958.50 to AmerisourceBergen Drug Corp for Hepatitis B vaccine (1 mL, 10-unit package) on December 19, 2025, with completion scheduled for December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $1,147.92 on August 5, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 6, 2025, and will be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $93,576.90 by the Defense Logistics Agency (DLA) on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract covers the supply of HEPLISAV-B 20 MCG/0.5 ML syringes, a hepatitis B vaccine product. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,061.12 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price contract, which is not set-aside, is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,359.98 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (hepatitis B vaccine) on September 22, 2025, with completion targeted for September 23, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATQADelivery Order
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,789.60 to AmerisourceBergen Drug Corp for BAYHEP VIAL 5ML 1S (Hepatitis B vaccine vials). This firm fixed-price delivery order, without set-aside designation, represents work to be performed in Conshohocken, Pennsylvania, with an ultimate completion date of February 2, 2026. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio includes delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Hepatitis B vaccine vials supports military medical readiness and immunization requirements across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/8/26 |